Skip to main content
Clinical Trials/NL-OMON31092
NL-OMON31092
Not Yet Recruiting
N/A

ature and mechanism of cognitive deficits following chemotherapy: an (f)MRI study - chemotherapy, cognition and (f)MRI

Antoni van Leeuwenhoek Ziekenhuis0 sites40 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
cognitive deficits
Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Enrollment
40
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • all groups:
  • \-sufficient proficiency in the Dutch language;cross\-sectional part:
  • \-participation in previous neuropsychological study
  • \-having been treated with high\-dose chemotherapy (CTC);prospective part, experimental group
  • \-newly diagnosed breast cancer patients without distant metastases that will receive chemotherapy (ACdd \+ T);prospective part, control group
  • \-newly diagnosed breast cancer patients without distant metastases that will not receive chemotherapy

Exclusion Criteria

  • \-relapse and/or metastases
  • \-excessive use of alcohol or drugs
  • \-use of psychotropic medication
  • \-neurologic or psychiatric disorders that may influence cognitive functioning
  • \-conditions that preclude MRI examination

Outcomes

Primary Outcomes

Not specified

Similar Trials